News
Is Reducing Specialty Drugs Coverage Penny-Wise, but Pound Foolish?
November 21, 2014
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD, Dana Goldman, PhD
Research
All Research Featured Research
Journal Article
The Value of Delaying Alzheimer’s Disease Onset
November 5, 2014
Featured Experts: Julie Zissimopoulos, PhD, Eileen Crimmins, PhD
Journal Article
Lack of Price Transparency: Extreme Variations in Costs for Brand Name and Generic Prescription Drugs as a Barrier for Uninsured Patients
October 31, 2014
Featured Experts: Neeraj Sood, PhD, Geoffrey Joyce, PhD
Evidence Base
Five Myths about Cancer Care in America
October 6, 2014
Featured Experts: Dana Goldman, PhD
Journal Article
Are Investments in Disease Prevention Complements? The Case of Statins and Health Behaviors
July 31, 2014
Featured Experts: Darius Lakdawalla, PhD
Journal Article
A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies
June 26, 2014
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Assessment of Therapeutic Preferences and Ideal Treatment Attributes among Adults with Cystic Fibrosis
May 19, 2014
Featured Experts: John Romley, PhD, Dana Goldman, PhD
Journal Article
Early HIV Treatment Led to Life Expectancy Gains Valued at $80 Billion for People Infected in 1996–2009.
April 1, 2014
Featured Experts: John Romley, PhD, Dana Goldman, PhD
Journal Article
Early HIV Treatment In The United States Prevented Nearly 13,500 Infections Per Year During 1996–2009
April 1, 2014
Featured Experts: Dana Goldman, PhD, John Romley, PhD
Journal Article
Do Strict Formularies Replicate Failure for Patients with Schizophrenia?
February 24, 2014
Featured Experts: Dana Goldman, PhD
Journal Article
Careful Use of Science to Advance the Debate on the UK Cancer Drugs Fund
January 1, 2014
Featured Experts: Darius Lakdawalla, PhD, Jason Doctor, PhD
Journal Article
Digesting the Doughnut Hole
December 1, 2013
Featured Experts: Geoffrey Joyce, PhD, Julie Zissimopoulos, PhD, Dana Goldman, PhD
Issue Brief
Innovation in Cancer Care: Value, Costs and Quality
January 2, 2012
Featured Experts: Darius Lakdawalla, PhD, John Romley, PhD
Journal Article
The Benefits From Giving Makers Of Conventional ‘Small Molecule’ Drugs Longer Exclusivity Over Clinical Trial Data
January 17, 2011
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, John Romley, PhD, Tomas Philipson, PhD
Journal Article
The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries
January 17, 2009
Featured Experts: Neeraj Sood, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD
Journal Article
U.S. Pharmaceutical Policy In A Global Marketplace
January 1, 2009
Featured Experts: Darius Lakdawalla, PhD, Neeraj Sood, PhD, Dana Goldman, PhD